Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: February 10, 2025 (11:52)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

This company is DELISTED
Latest session on the 28th of December for
Dicerna Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 38.22 /  High: 38.22 /  Low: 38.22
Current value: $38.22

Are you interested in Dicerna Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Dicerna Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Dicerna Pharmaceuticals stock? When should I record a loss on Dicerna Pharmaceuticals stock? What are analysts' forecasts for Dicerna Pharmaceuticals stock? What is the future of Dicerna Pharmaceuticals stock? We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Dicerna Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Dicerna Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Trending Themes in the Healthcare Sector

Dicerna Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Feb 12 37.55 37.30 38.08 2.08
Feb 13 37.22 36.55 37.70 3.15
Feb 14 37.11 36.26 37.73 4.05
Feb 15 37.22 36.64 37.50 2.35
Feb 16 37.15 36.67 37.55 2.40
Feb 17 37.01 36.17 37.24 2.95
Feb 18 37.40 37.16 37.81 1.75
Feb 19 37.67 37.39 38.44 2.81
Feb 20 37.08 36.42 37.67 3.42
Feb 21 36.97 36.36 37.20 2.32
Feb 22 37.30 36.49 37.57 2.94
Feb 23 37.69 36.92 38.24 3.58
Feb 24 37.20 36.67 37.93 3.44
Feb 25 37.03 36.14 37.25 3.07
Feb 26 37.15 36.28 37.43 3.16
Feb 27 36.89 36.40 37.50 3.01
Feb 28 37.27 36.79 38.12 3.62
Mar 01 38.05 37.55 38.45 2.40
Mar 02 38.48 37.81 38.83 2.69
Mar 03 38.38 37.51 39.12 4.30
Mar 04 38.71 38.44 39.31 2.27
Mar 05 38.63 37.95 39.24 3.39
Mar 06 38.75 37.88 39.21 3.53
Mar 07 39.24 38.78 39.66 2.28
Mar 08 39.40 38.59 40.08 3.86
Mar 09 39.37 38.60 40.19 4.13
Mar 10 38.34 37.44 38.81 3.66
Mar 11 38.79 38.47 39.47 2.60
Mar 12 39.30 38.44 40.11 4.36
Mar 13 39.26 38.42 39.66 3.25

Dicerna Pharmaceuticals Daily Price Targets


Dicerna Pharmaceuticals Stock Forecast 02-12-2025.

Forecast target price for 02-12-2025: $37.55.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.041%.
Pessimistic target level: 37.30
Optimistic target level: 38.08

Dicerna Pharmaceuticals Stock Forecast 02-13-2025.

Forecast target price for 02-13-2025: $37.22.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.051%.
Pessimistic target level: 36.55
Optimistic target level: 37.70

Dicerna Pharmaceuticals Stock Forecast 02-14-2025.

Forecast target price for 02-14-2025: $37.11.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.894%.
Pessimistic target level: 36.26
Optimistic target level: 37.73

Dicerna Pharmaceuticals Stock Forecast 02-15-2025.

Forecast target price for 02-15-2025: $37.22.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.293%.
Pessimistic target level: 36.64
Optimistic target level: 37.50

Dicerna Pharmaceuticals Stock Forecast 02-16-2025.

Forecast target price for 02-16-2025: $37.15.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.345%.
Pessimistic target level: 36.67
Optimistic target level: 37.55

Dicerna Pharmaceuticals Stock Forecast 02-17-2025.

Forecast target price for 02-17-2025: $37.01.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.862%.
Pessimistic target level: 36.17
Optimistic target level: 37.24

DRNA (DRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Mar. 37.24 33.31 42.01 20.71
Apr. 37.06 35.34 41.45 14.74
May. 38.66 35.82 40.95 12.54
Jun. 41.45 36.47 44.70 18.40
Jul. 43.04 37.53 46.07 18.54
Aug. 49.24 46.79 51.84 9.73
Sep. 55.22 49.22 57.08 13.78
Oct. 51.25 48.38 56.91 14.99
Nov. 54.53 50.69 59.15 14.31
Dec. 56.19 54.03 60.05 10.03

Dicerna Pharmaceuticals forecast for this year


Dicerna Pharmaceuticals Stock Prediction for Mar 2025

An downtrend is forecast for this month with an optimal target price of $37.2416. Pessimistic: $33.31. Optimistic: $42.01


Dicerna Pharmaceuticals Stock Prediction for Apr 2025

An downtrend is forecast for this month with an optimal target price of $37.0628. Pessimistic: $35.34. Optimistic: $41.45


Dicerna Pharmaceuticals Stock Prediction for May 2025

An uptrend is forecast for this month with an optimal target price of $38.6639. Pessimistic: $35.82. Optimistic: $40.95


Dicerna Pharmaceuticals Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $41.4477. Pessimistic: $36.47. Optimistic: $44.70


Dicerna Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $43.0393. Pessimistic: $37.53. Optimistic: $46.07


Dicerna Pharmaceuticals Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $49.237. Pessimistic: $46.79. Optimistic: $51.84


Dicerna Pharmaceuticals Stock Prediction for Sep 2025

An uptrend is forecast for this month with an optimal target price of $55.2242. Pessimistic: $49.22. Optimistic: $57.08


Dicerna Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $51.2481. Pessimistic: $48.38. Optimistic: $56.91


Dicerna Pharmaceuticals Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $54.5279. Pessimistic: $50.69. Optimistic: $59.15


Dicerna Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $56.1856. Pessimistic: $54.03. Optimistic: $60.05



Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 48.01 43.32 51.85 16.44
Feb 42.94 41.56 46.58 10.77
Mar 46.44 43.91 49.86 11.92
Apr 53.57 48.43 60.09 19.40
May 57.86 54.90 65.17 15.77
Jun 57.67 54.72 62.47 12.41
Jul 54.44 48.52 60.37 19.62
Aug 56.80 54.07 59.70 9.44
Sep 62.25 54.78 66.43 17.54
Oct 63.14 55.67 66.98 16.89
Nov 59.81 55.89 62.39 10.43
Dec 55.69 53.02 58.90 9.98

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 48.21 42.81 52.37 18.26
Feb 51.99 45.50 55.73 18.36
Mar 55.90 51.25 60.82 15.74
Apr 62.34 57.95 69.92 17.12
May 59.94 57.83 65.03 11.06
Jun 61.48 58.33 66.10 11.76
Jul 60.79 53.79 63.61 15.44
Aug 54.57 49.50 60.42 18.06
Sep 55.79 50.97 57.66 11.61
Oct 56.32 52.18 61.91 15.72
Nov 65.25 60.55 69.53 12.91
Dec 70.99 66.90 77.57 13.76

Dicerna Pharmaceuticals information and performance

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Dicerna Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DRNA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Dicerna Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Dicerna Pharmaceuticals Stock)

Should I Buy Dicerna Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $63.14, which is $24.92 higher than the current stock price. By investing in Dicerna Pharmaceuticals shares today for a one-year period, you could achieve a profit of 65.21%. With an investment horizon of up to two years, the target share price is $70.99. resulting in a profit of 85.73% ($32.77 per share).

Does Dicerna Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Dicerna Pharmaceuticals's shares belong to?

Dicerna Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Dicerna Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Dicerna Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.